Innovative Discovery Platform

Utilizing Corridor’s proprietary platform, the Company has discovered the first, highly potent, small molecule inhibitors of arginase, a novel mechanism, shown to be involved in the progression of a number of pulmonary diseases.

Resources

Arginase inhibition mediates cardioprotection during ischaemia–reperfusion

Cardiovascular Research. 2010; 85: 147-154.